The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Goodwin, R. D.
* Articles by Gorman, J. M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Goodwin, R. D.
* Articles by Gorman, J. M.
Related Collections
* Anxiety Disorders (General)
* Depression
Am J Psychiatry 159:1935-1937, November 2002
© 2002 American Psychiatric Association


Brief Report

Psychopharmacologic Treatment of Generalized Anxiety Disorder and the Risk of Major Depression

Renée D. Goodwin, Ph.D., and Jack M. Gorman, M.D.

OBJECTIVE: The authors sought to determine the association between treatment for generalized anxiety disorder and the risk of major depression among adults in the community. METHOD: Data were drawn from the National Comorbidity Survey (N=8,098), a representative sample of the United States population age 15–54. Cox proportional hazards were used to determine the association between specific forms of treatment for generalized anxiety disorder and the risk of major depression. RESULTS: Psychopharmacologic treatment of generalized anxiety disorder was associated with a significantly lower risk of major depression. There was no significant association between either having seen a mental health professional for generalized anxiety disorder or having been prescribed a medication for generalized anxiety disorder and the risk of depression. CONCLUSIONS: These results suggest an association between treatment for generalized anxiety disorder and lower risk of depression, which appears specific to pharmacologic treatment. Future research that leads to a more precise delineation of the underlying mechanism of the observed association is needed to identify and develop effective strategies to prevent onset of depression.




This article has been cited by other articles:


Home page
Evid. Based Ment. HealthHome page
D. J Stein
Pregabalin and venlafaxine improve symptoms of generalised anxiety disorder
Evid. Based Ment. Health, February 1, 2007; 10(1): 23 - 23.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. J. M. H. Strik, J. Denollet, R. Lousberg, and A. Honig
Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction
J. Am. Coll. Cardiol., November 19, 2003; 42(10): 1801 - 1807.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. NewsHome page
J. Rosack

Psychiatr News, November 1, 2002; 37(21): 26 - 26.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org